Oseltamivir analogs with potent anti-influenza virus activity.
Oseltamivir analogs with potent anti-influenza virus activity.
Drug Discov Today. 2020 Jun 15;:
Authors: Kumar S, Goicoechea S, Kumar S, Pearce CM, Durvasula R, Kempaiah P, Rathi B, Poonam
Abstract
Influenza A and B viruses cause seasonal worldwide influenza epidemics each winter, and are a major public health concern and cause of morbidity and mortality. A substantial reduction in influenza-related deaths can be attributed to both vaccination and administration of oseltamivir (OS), which is approved for oral administration and inhibits viral neuraminidase (NA), a transmembrane protein. OS carboxylate (OSC), the active form of OS, is formed by the action of endogenous esterase, which targets NA and is shown to significantly reduce influenza-related deaths. However, the development of resistance in various viral variants, including H3N2 and H5N1, has raised concern about the effectiveness of OS. This comprehensive review covers a range of OS analogs shown to be effective against influenza virus, comparing different types of substituent group that contribute to the activity and bioavailability of these compounds.
PMID: 32554062 [PubMed - as supplied by publisher]
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Kumar S, Goicoechea S, Kumar S, Pearce CM, Durvasula R, Kempaiah P, Rathi B, Poonam Tags: Drug Discov Today Source Type: research
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Drugs & Pharmacology | Epidemics | Epidemiology | H3N2 | H5N1 | Influenza | Influenza Vaccine | International Medicine & Public Health | Oseltamivir | Tamiflu | Vaccines